REG - Primorus Investments - Alteration Earth update

Primorus InvestmentsAnnouncement

24/12/2021 10:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211224:nRSX7698Wa&default-theme=true

RNS Number : 7698W  Primorus Investments PLC  24 December 2021

Primorus Investments plc

 

("Primorus" or the "Company")

 

Update on Alteration Earth PLC Investment

 

Further to the RNS announcement dated 21 October 2021, in relation to the
Company's investment in Alteration Earth PLC ("ALTE"), Primorus provides a
brief update as set out below.

 

Primorus has signed a deed of amendment which extends the time period for ALTE
to complete its prospectus and obtain its listing on the Standard Segment of
the Main Market of the London Stock Exchange.

 

The date has been extended from 31 December 2021 to 4 February 2022.  The
extension has mainly been due to the rule changes and the Christmas operating
hours of the Financial Conduct Authority ("FCA") - details of both can be
found here:

 

https://www.fca.org.uk/publication/policy/ps21-22.pdf
(https://www.fca.org.uk/publication/policy/ps21-22.pdf)

 

https://www.fca.org.uk/markets/listing-transactions-over-christmas-and-new-year
(https://www.fca.org.uk/markets/listing-transactions-over-christmas-and-new-year)

 

The Prospectus has been submitted for its second reading and ALTE expects to
receive the FCA comments early in January.  Following this, and assuming no
material issues are raised, ALTE is expecting to obtain its listing without
any further amendments to the timeframe.

 

For further information please contact:

 

 Primorus Investments plc

 Matthew Beardmore, Chief Executive Officer   +44 (0)20 8154 7907

 Nominated Adviser

 Cairn Financial Advisers LLP                 +44 (0) 20 7213 0880

 Sandy Jamieson/James Caithie

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURFLFIIFALSFIL